TP53 and colorectal carcinoma: Simultaneous vector-mediated transduction of both p53 and p21 mRNA into hepatocellular and colorectal carcinoma cells performed in a recent study (Idogawa et al, 2009) was shown to increase rates of apoptotic cell death and also act synergistically with doxorubicin, thus having important therapeutic implications.